The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Elevation of glutathione as a therapeutic strategy in Alzheimer disease
Open accessAbstract
Oxidative stress has been associated with the onset and progression of mild cognitive impairment (MCI) and Alzheimer disease (AD). AD and MCI brain and plasma display extensive oxidative stress as indexed by protein oxidation, lipid peroxidation, free radical formation, DNA oxidation, and decreased antioxidants. The most abundant endogenous antioxidant, glutathione, plays a significant role in combating oxidative stress. The ratio of oxidized to reduced glutathione is utilized as a measure of intensity of oxidative stress. Antioxidants have long been considered as an approach to slow down AD progression. In this review, we focus on the elevation on glutathione through N-acytl-cysteine (NAC) and γ-glutamylcysteine ethyl ester (GCEE) as a potential therapeutic approach for Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationPraticò, D., Clark, C. M., Liun, F., Lee, V. Y.-M., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 584
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationCastegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Self-citationEvidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationThe prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
Selkoe, D. J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3111 · Cited by 466
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Self-citationFarr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459
Self-citationAPP processing is regulated by cytoplasmic phosphorylation
Lee, M.-S., Kao, S.-C., Lemere, C. A., Xia, W., Tseng, H.-C., Zhou, Y., Neve, R., Ahlijanian, M. K., & Tsai, L.-H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301115 · Cited by 454
Mild cognitive impairment: transition between aging and Alzheimer's disease.
Petersen, R. C. (2000) · PubMed · Cited by 395
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Self-citationDrake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05088.2003 · Cited by 337
Chrestensen, C. A., Starke, D. W., & Mieyal, J. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004097200 · Cited by 331
Praticò, D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.010 · Cited by 313
Butterfield, D. A., Bader Lange, M. L., & Sultana, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.005 · Cited by 299
Self-citationDecreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275
Butterfield, D. A., Hardas, S. S., & Lange, M. L. B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1375 · Cited by 262
Self-citationEstus, S., Tucker, H. M., van Rooyen, C., Wright, S., Brigham, E. F., Wogulis, M., & Rydel, R. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07736.1997 · Cited by 258
Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257
Self-citationRenes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 253
Self-citationOxidative damage in mild cognitive impairment and early Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245
Lee, M., Cho, T., Jantaratnotai, N., Wang, Y. T., McGeer, E., & McGeer, P. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-149997 · Cited by 243
Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease
Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240
Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis.
Anderson, M. E., & Meister, A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.707 · Cited by 240
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15314 · Cited by 237
Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome
Sultana, R., Boyd-Kimball, D., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., & Butterfield, D. A. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11203 · Cited by 230
Self-citationCalabrese, V., Sultana, R., Scapagnini, G., Guagliano, E., Sapienza, M., Bella, R., Kanski, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227
Self-citationLloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Self-citationMultifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism
Butterfield, D. A., & Lange, M. L. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06397.x · Cited by 177
Self-citationNewman, S. F., Sultana, R., Perluigi, M., Coccia, R., Cai, J., Pierce, W. M., Klein, J. B., Turner, D. M., & Butterfield, D. A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21275 · Cited by 166
Self-citationPocernich, C. B., La Fontaine, M., & Butterfield, D. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00126-6 · Cited by 165
Self-citationPrevention of PC12 Cell Death by N-Acetylcysteine Requires Activation of the Ras Pathway
Yan, C. Y. I., & Greene, L. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04042.1998 · Cited by 162
Pahan, K., Sheikh, F. G., Namboodiri, A. M. S., & Singh, I. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00137-8 · Cited by 161
Fuller, S. L., Steele, M. L., & Münch, G. W. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.016 · Cited by 158
Peripheral Oxidative Damage in Mild Cognitive Impairment and Mild Alzheimer's Disease
Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15110 · Cited by 157
Greilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., & Oettl, K. (2008) · Free Radical Research · doi:10.1080/10715760802255764 · Cited by 153
Rukhsana Sultana, A., & Butterfield, D. A. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7028-0 · Cited by 153
Self-citationInhibition of beta 1–40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots
Xiao, L., Zhao, D., Chan, W. H., Choi, M. M. F., & Li, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.014 · Cited by 146
Glutathione Therapy: From Prodrugs to Genes
Anderson, M. E., & Luo, J. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007174 · Cited by 141
Age-associated decline in γ-glutamylcysteine synthetase gene expression in rats
Liu, R.-M., & Choi, J. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00269-5 · Cited by 139
Fu, A., Dong, Z., & Sun, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.042 · Cited by 137
Bars, P. L., Velasco, F. M., Ferguson, J. M., Dessain, E. C., Kieser, M., & Hoerr, R. (2002) · Neuropsychobiology · doi:10.1159/000048668 · Cited by 132
Oxidized neprilysin in aging and Alzheimer’s disease brains
Wang, D.-S., Iwata, N., Hama, E., Saido, T. C., & Dickson, D. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.003 · Cited by 131
Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease
Pocernich, C. B., Lange, M. L. B., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391908 · Cited by 130
Self-citationRemington, R., Chan, A., Paskavitz, J., & Shea, T. B. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317508325094 · Cited by 129
Rukhsana Sultana, A., Piroddi, M., Galli, F., & Butterfield, D. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9593-0 · Cited by 117
Self-citationDrake, J., Rukhsana Sultana, A., Aksenova, M. V., Calabrese, V., & Butterfield, D. A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10810 · Cited by 117
Self-citationWalsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., & Teplow, D. B. (2001) · Biochemical Journal · doi:10.1042/bj3550869 · Cited by 115
Sultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101425 · Cited by 111
Self-citationDrake, J., Kański, J., Varadarajan, S., Tsoras, M., & Butterfield, D. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10266 · Cited by 109
Self-citationOlivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 99
Decreased Neprilysin Immunoreactivity in Alzheimer Disease, but Not in Pathological Aging
Wang, D.-S., Lipton, R. B., Katz, M. J., Davies, P. J., Herman Buschke, L., Kuslansky, G., Verghese, J., Younkin, S. G., Eckman, C., & Dickson, D. W. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.5.378 · Cited by 96
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 92
Self-citationHuang, Q., Aluise, C. D., Gururaj Joshi, A., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22422 · Cited by 91
Self-citationOxidative Damage and Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment
Baldeiras, I., Santana, I. J., Proença, M. T., Garrucho, M. H., Pascoal, R., Rodrigues, A. P., Duro, D., & Oliveira, C. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091723 · Cited by 90
Fawzi, N. L., Okabe, Y., Yap, E.-H., & Head-Gordon, T. L. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.011 · Cited by 90
Domenico, F. D., Cenini, G., Rukhsana Sultana, A., Marzia Perluigi, A., Uberti, D. L., Memo, M., & Butterfield, D. A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9924-9 · Cited by 77
Self-citationGlutathione transferase protects neuronal cultures against four hydroxynonenal toxicity
Xie, C., Lovell, M. A., & Markesbery, W. R. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00186-5 · Cited by 72
Glucose intolerance, cognitive impairment and Alzheimer’s disease
Vanhanen, M., & Soininen, H. S. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199812000-00011 · Cited by 72
Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 72
Self-citationDebra Boyd-kimball, A., Rukhsana Sultana, A., Abdul, H. M., & Butterfield, D. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20394 · Cited by 66
Self-citationTucker, S., Ahl, M., Cho, H.-H., Bandyopadhyay, S., Cuny, G., Bush, A., Goldstein, L., Westaway, D., Huang, X., & Rogers, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506777632835 · Cited by 62 · cited 1×
“All rights reserved.”
Medina, S., Martínez, M., & Hernánz, Á. (2002) · Free Radical Research · doi:10.1080/107157602100006445 · Cited by 61
Koppal, T., Drake, J., & Butterfield, D. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00014-9 · Cited by 52
Self-citationDebra Boyd-kimball, A., Rukhsana Sultana, A., Poon, H. F., Abdul, H. M., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20393 · Cited by 51
Self-citationXu, Y., Hou, X., Liu, Y. U., & Zong, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21909 · Cited by 40
Studer, R. O., Baysang, G., & Brack, C. (2001) · Biogerontology · doi:10.1023/a:1010065103073 · Cited by 28
Gamma-glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion
Hoshida, S., Kuzuya, T., Yamashita, N., Nishida, M., Kitahara, S., Hori, M., Kamada, T., & Tada, M. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90125-2 · Cited by 26
Hsiao, Y., Chen, P. S., Yeh, S.-H., Lin, C., & Gean, P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21710 · Cited by 25
Wang, R., Malter, J. S., & Wang, D.-S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1226 · Cited by 18
Turunç, E., Kanıt, L., & Yalçın, A. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01122.x · Cited by 11
Okamoto, T., Mizuta, K., Takahashi, T., Kishi, T., Kitahara, S., Komori, S., Hashimoto, K., & Goshima, K. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00361-x · Cited by 11
[What is a mild cognitive impairment?].
Portet, F., Ousset, P., & Touchon, J. (2005) · PubMed · Cited by 11
Zhang, Q., Tian, H., Fu, X., & Zhang, G. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.025 · Cited by 8
Cited by
Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents
Sedgwick, A. C., Wu, L., Han, H.-H., Bull, S. D., He, X.-P., James, T. D., Sessler, J. L., Tang, B. Z., Tian, H., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00185e · Cited by 1,569
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
The role of glutathione reductase and related enzymes on cellular redox homoeostasis network
Couto, N., Wood, J., & Barber, J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.028 · Cited by 1,006
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
Wang, W., Sun, C., Mao, L., Ma, P., Liu, F., Yang, J., & Gao, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.07.004 · Cited by 784
Metadata
- Authors
- Pocernich, C. B., & Butterfield, D. A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 1822
- Issue
- 5
- Pages
- 625-630
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W1967013632
- Cited by
- 346
- References
- 83
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.